Show overview
ERS Publications Podcasts has been publishing since 2017, and across the 9 years since has built a catalogue of 84 episodes. That works out to roughly 25 hours of audio in total. Releases follow a roughly quarterly cadence.
Episodes typically run ten to twenty minutes — most land between 12 min and 20 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.
The show is actively publishing — the most recent episode landed 3 weeks ago, with 7 episodes already out so far this year. The busiest year was 2024, with 17 episodes published.
From the publisher
Our ERS Publications podcasts feature: a monthly podcast from the European Respiratory Journal, which summarises the research findings of a number of papers published in each issue; podcasts from our book series, the ERS Monograph, with each relating to current book's topic of focus.
Latest Episodes
View all 84 episodesERJ Podcast May 2026: Mucus plugs in asthma and COPD
Bronchiectasis
ERJ Podcast April 2026: Use of spirometry to define airflow obstruction and diagnose COPD
ERJ Podcast March 2026: Mortality in severe asthma
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Susanne Hansen (Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, and Centre for Clinical Research and Prevention, Frederiksberg Hospital, Copenhagen, Denmark) about her article on mortality in severe asthma as revealed by results from the NORDSTAR cohort, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02244-2025). Cite this podcast as: ERJ Podcast March 2026: Mortality in severe asthma. Eur Respir J 2026; 67: 26E6703 [https://doi.org/10.1183/13993003.E6703-2026].
ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews David Halpin (University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK) about his Viewpoint editorial on a shared vision from the Global Initiative for Chronic Obstructive Lung Disease and the Global Initiative for Asthma of how to address the global challenges of COPD and asthma, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02244-2025). Cite this podcast as: ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma. Eur Respir J 2026; 67: 26E6702 [https://doi.org/10.1183/13993003.E6702-2026].

ERS Monograph: Chronic Cough
"Even now, many patients remain misunderstood and mislabelled by their clinician and their family, and even by our society." In this instalment of the ERS Monograph podcast, Guido Marchi (Early Career Member representative for the Monograph) meets with the Guest Editors of Chronic Cough: Woo-Jung Song, Lorcan McGarvey, Peter S.P. Cho and Kian Fan Chung. They reflect on the way in which chronic cough has evolved from being just a symptom of other diseases to an independent condition recognised for its complexity. In a lively and informative discussion, they cover topics such as antitussive development, the key tools and methods of chronic cough assessment, and the importance of a multidisciplinary team in the cough clinic.
ERJ Podcast January 2026: Cannabis and the lung
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Janice Leung about the clinical, physiological, imaging and molecular responses to cannabis smoking seen in the Canadian Users of Cannabis Smoke study published in this issue of the ERJ (https://doi.org/10.1183/13993003.01659-2025). Cite this podcast as: ERJ Podcast January 2026: Cannabis and the lung. Eur Respir J 2026; 67: 26E6701 [https://doi.org/10.1183/13993003.E6701-2026].
ERJ Podcast December 2025: Year in review
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin for their end-of-year roundup of their highlights from the ERJ in 2025. Cite this podcast as: ERJ Podcast December 2025: Year in review. Eur Respir J 2025; 66: 25E6606. [doi.org/10.1183/13993003.E6606-2025]
ERJ Podcast November 2025: Artificial intelligence in publishing
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers, Deputy Chief Editor Don Sin and European Respiratory Review Chief Editor Rory Morty discuss the merits and pitfalls of the rapidly increasing use of generative AI in scientific publishing. Cite this podcast as: ERJ Podcast November 2025: Artificial intelligence in publishing. Eur Respir J 2025; 66: 25E6605. [doi.org/10.1183/13993003.E6605-2025]
ERJ Podcast October 2025: Natural disasters and respiratory health
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024 Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]

ERS Monograph: Pulmonary Hypertension
"Although we have learned a lot about this disease [...] we still need to improve awareness. That means colleagues have to think that the patient may have pulmonary hypertension." In this episode, Dorina Esendagli (the Monograph's Early Career Member representative) meets with Gabor Kovacs to discuss the recent Monograph on "Pulmonary Hypertension", which he co-Guest Edited with Athénaïs Boucly and Robin Condliffe. Gabor explains how the Monograph addresses diagnosis and can be used to guide the nonspecialist, highlights the importance of the multidisciplinary team, and brings important areas of future research into focus.
ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025 Correction: At 5 min 54 s in this podcast, in response to a question from D. Sin regarding the dosing of azithromycin, M. Mall mistakenly replied that “For the immunomodulatory effects, it would be a standard long-term therapy with a three times per day regimen.” He meant to say “three times per week”. We apologise for this error. Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025]
ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany) about the European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea with adaptive servo-ventilation in this issue of the ERJ: https://doi.org/10.1183/13993003.00263-2025 Cite this podcast as: ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation. Eur Respir J 2025; 66: 25E6602 [doi.org/10.1183/13993003.E6602-2025].

ERS Monograph: Asthma
“We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice” Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients.
ERJ Podcast July 2025: Implementation of European national driving regulations for OSA
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Walter McNicholas (School of Medicine and the Conway Research Institute, University College Dublin, and Department of Respiratory and Sleep Medicine, St Vincent’s Hospital Group, Dublin, Ireland) about the challenges of implementing European national driving regulations for obstructive sleep apnoea, as discussed in Prof. McNicholas’ article in this issue of the ERJ: https://doi.org/10.1183/13993003.02484-2024 Cite this podcast as: ERJ Podcast July 2025: Implementation of European national driving regulations for OSA. Eur Respir J 2025; 66: 25E6601 [https://doi.org/10.1183/13993003.E6601-2025].
ERJ Podcast January 2025: Treatment response to mepolizumab in severe eosinophilic asthma
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Peter Gibson about distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma.
ERJ Podcast June 2025: Mechanistic studies in interstitial lung disease
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Bruno Crestani about a series of articles published in the June issue of the ERJ on mechanistic studies in interstitial lung disease: building translational bridges in IPF research.
ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.
ERJ Podcast April 2025: Continuous positive airway pressure and mandibular advancement splints
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Fernanda Almeida about the CHOICE multicentre, open-label randomised clinical trial.

ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.